Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Breathtec Biomedical Inc (BTHCF)

Breathtec Biomedical Inc (BTHCF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BTHCF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0270 +34.44%
on 12/04/19
0.0648 -43.98%
on 12/05/19
+0.0013 (+3.71%)
since 11/27/19
3-Month
0.0270 +34.44%
on 12/04/19
0.1500 -75.80%
on 10/23/19
-0.0462 (-56.00%)
since 09/27/19
52-Week
0.0270 +34.44%
on 12/04/19
0.3982 -90.88%
on 02/19/19
-0.0517 (-58.75%)
since 12/27/18

Most Recent Stories

More News
Algernon Pharmaceuticals Announces Ifenprodil Reduced Interleukin 6 in Phase 2b/3 COVID Study

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the "Company" or "Algernon") a clinical stage pharmaceutical development company announces that NP-120 (Ifenprodil) reduced interleukin...

AGNPF : 0.0741 (+1.23%)
AGN.CN : 0.090 (unch)
BTHCF : 0.0363 (-11.46%)
Algernon Pharmaceuticals Announces 50% Enrollment of its Ifenprodil IPF and Chronic Cough Phase 2 Human Study

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the "Company" or "Algernon") a clinical stage pharmaceutical development company is pleased to announce that it has reached 50%...

AGNPF : 0.0741 (+1.23%)
AGN.CN : 0.090 (unch)
BTHCF : 0.0363 (-11.46%)
Algernon Pharmaceuticals Appoints Dr. Mark Swaim MD, PhD to its Medical and Scientific Advisory Board

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the "Company" or "Algernon") a clinical stage pharmaceutical development company is pleased to announce that Dr. Mark Swaim, a former...

AGN.CN : 0.090 (unch)
BTHCF : 0.0363 (-11.46%)
Algernon Pharmaceuticals Appoints Leading Respirologist Dr. Martin Kolb to Its Medical and Scientific Advisory Board

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the "Company" or "Algernon"), a clinical stage pharmaceutical development company, is pleased to announce that Dr. Martin Kolb,...

AGN.CN : 0.090 (unch)
BTHCF : 0.0363 (-11.46%)
Algernon Pharmaceuticals to Present at 12th Annual LD Micro Main Event Conference on Wednesday December 11, 2019

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the "Company" or "Algernon"), a clinical stage pharmaceutical development company, is pleased to announce that it will present at...

AGN.CN : 0.090 (unch)
BTHCF : 0.0363 (-11.46%)
Algernon Pharmaceuticals Selects NP-120 (Ifenprodil) for its Lead Phase 2 Trial for Idiopathic Pulmonary Fibrosis and Chronic Cough

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the "Company" or "Algernon"), a clinical stage pharmaceutical development company, is pleased to announce that it plans to conduct...

AGN.CN : 0.090 (unch)
BTHCF : 0.0363 (-11.46%)
Algernon Pharmaceuticals' NP-120 (Ifenprodil) Outperforms Merck's Phase 3 Drug MK-7264 (Gefapixant) in an Acute Cough Study by 110%

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the "Company" or "Algernon"), a clinical stage pharmaceutical development company, is pleased to announce that NP-120 (Ifenprodil),...

MRK : 71.64 (-0.06%)
AGN.CN : 0.090 (unch)
BTHCF : 0.0363 (-11.46%)
Algernon Pharmaceuticals Provides Update on its Planned Phase II Clinical Trial

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the "Company" or "Algernon"), a clinical stage pharmaceutical development company, is pleased to provide an update to the market...

AGN.CN : 0.090 (unch)
BTHCF : 0.0363 (-11.46%)
Algernon Announces Closing of $2.07 Million Prospectus Offering of Units

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

AGN.CN : 0.090 (unch)
BTHCF : 0.0363 (-11.46%)
Algernon Announces Pricing and Filing of Amended and Restated Prospectus

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

AGN.CN : 0.090 (unch)
BTHCF : 0.0363 (-11.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.0456
1st Resistance Point 0.0409
Last Price 0.0363
1st Support Level 0.0339
2nd Support Level 0.0316
3rd Support Level N/A

See More

52-Week High 0.3982
Fibonacci 61.8% 0.2564
Fibonacci 50% 0.2126
Fibonacci 38.2% 0.1688
Last Price 0.0363
52-Week Low 0.0270

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar